A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT05706129 · RECRUITING

Trial details

NCT number: NCT05706129
Sponsor: Lumara Bio Oncologics GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Urothelial Carcinoma (UC)Indeterminate Renal Mass (IDRM)Muscle Invasive Bladder Cancer (MIBC)Head and Neck Cancer (H&N)Triple Negative Breast Cancer (TNBC)Squamous Non-Small Cell Lung Cancer (NSCLC)

Start date: 2023-03-14
Primary completion: 2027-06-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.